{"id":1264,"date":"2006-11-01T12:04:00","date_gmt":"2006-11-01T11:04:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2006\/unerwuenschte-arzneimittelwirkungen-von-atorvastatin-gabapentin-und-methadon"},"modified":"2006-11-01T12:04:00","modified_gmt":"2006-11-01T11:04:00","slug":"unerwuenschte-arzneimittelwirkungen-von-atorvastatin-gabapentin-und-methadon","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2006\/unerwuenschte-arzneimittelwirkungen-von-atorvastatin-gabapentin-und-methadon","title":{"rendered":"Unerw\u00fcnschte Arzneimittelwirkungen von Atorvastatin, Gabapentin und Methadon"},"content":{"rendered":"<p>Unter der Rubrik \u201eDrug points\u201d berichtet das BMJ \u00fcber folgende, vermutlich seltene, unerw\u00fcnschte Wirkungen von Arzneimitteln (UAW): Eine 72-j\u00e4hrige Frau, die an Hypertonie, Hypothyreose, Herzinsuffizienz und Niereninsuffizienz litt, wurde seit l\u00e4ngerer Zeit mit L-Thyroxin, Amlodipin, Atenolol und Losartan (Lorzaar\u00ae) behandelt. F\u00fcnf Tage nach Beginn einer Therapie mit 10 mg Atorvastatin (Sortis\u00ae) abends litt sie f\u00fcr [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Unter der Rubrik \u201eDrug points\u201d berichtet das BMJ \u00fcber folgende, vermutlich seltene, unerw\u00fcnschte Wirkungen von Arzneimitteln (UAW): Eine 72-j\u00e4hrige Frau, die an Hypertonie, Hypothyreose, Herzinsuffizienz und Niereninsuffizienz litt, wurde seit l\u00e4ngerer Zeit mit L-Thyroxin, Amlodipin, Atenolol und Losartan (Lorzaar\u00ae) behandelt. F\u00fcnf Tage nach Beginn einer Therapie mit 10 mg Atorvastatin (Sortis\u00ae) abends litt sie f\u00fcr [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[3112,3111,1046,451,449,236,3113,3114,455,453,2484,456,19,633,505,443,231],"class_list":["post-1264","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-albtraeume","tag-amenorrhoe","tag-atorvastatin","tag-cholesterinsynthese-hemmer","tag-cse-hemmer","tag-gabapentin","tag-galaktorrhoe","tag-gesichtsfeldeinengung","tag-hmg-coa-reduktase-hemmer","tag-hypercholesterinaemie","tag-hyperprolaktinaemie","tag-lipidsenker","tag-methadon","tag-metoprolol","tag-simvastatin","tag-statine","tag-vigabatrin"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1264","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=1264"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1264\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=1264"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=1264"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=1264"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}